E-Cigarette and Vaping Product Use Associated Lung Injury (EVALI)
The Centers for Disease Control and Prevention (CDC) is investigating a multistate outbreak of lung injury associated with use of e-cigarette, or vaping, products. Healthcare providers and clinicians should report any suspected cases of EVALI to their local health department.
- DHEC Health Alert Network
- CDC Clinical Outreach and Communication Activity Clinical Action Alert
- Outbreak of Lung Disease Associated with E-Cigarettes, or Vaping (CDC)
- Update: Interim Guidance for Healthcare Providers
The SC Department of Health and Environmental Control (DHEC) is participating in the Centers for Disease Control and Prevention (CDC) investigation of E-cigarette and Vaping Product Use Associated Lung Injury (EVALI). Laboratory data show that vitamin E acetate, an additive in some THC-containing e-cigarette, or vaping, products, is closely associated with EVALI. However, there are many different substances and product sources that are still being investigated, and there may be more than one cause.
As of January 7, 2020, the CDC is reporting 2,602* cases of e-cigarette, or vaping, product use associated lung injury (EVALI) from all 50 states, the District of Columbia, and 2 U.S. territories. Fifty-seven deaths have been confirmed in 27 states and the District of Columbia.
South Carolina is investigating reports of EVALI in all four regions of the state. Cases range in age from 13-69.
|SC Cases of E-Cigarette and Vaping Product Use Associated Lung Injury (EVALI)|
|Number of Deaths||1|
Find more e-cigarette risk information on the DHEC E-cigarettes, Vapes, and Other Tobacco Products page.
*The increase in lung injury cases from last week represents both new patients and recent reporting of previously-identified patients to CDC.